The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Open accessAbstract
Glycogen synthase kinase 3β (GSK3β), a multifunctional serine/threonine kinase found in all eukaryotes, had been initially identified as a key regulator of insulin-dependent glycogen synthesis. It is now known that GSK3β functions in diverse cellular processes including proliferation, differentiation, motility and survival. Aberrant regulation of GSK3β has been implicated in a range of human pathologies including non-insulin-dependent diabetes mellitus, cardiovascular disease, some neurodegenerative diseases, and bipolar disorder. As a consequence, the therapeutic potential of GSK3β inhibitors has become an important area of investigation. However, GSK3β also participates in neoplastic transformation and tumor development. The role of GSK3β in tumorigenesis and cancer progression remains controversial; it may function as a “tumor suppressor” for certain types of tumors, but promotes growth and development for some others. GSK3β also mediates drug sensitivity/resistance in cancer chemotherapy. Therefore, although GSK3β is an attractive therapeutic target for a number of human diseases, its potential impact on tumorigenesis and cancer chemotherapy needs to be carefully evaluated. This mini-review discusses the role of GSK3β in tumorigenesis/cancer progression as well as its modulation of cancer chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Self-citationThe role of epithelial-mesenchymal transition in cancer pathology
guarino, M., rubino, B., & ballabio, G. (2007) · Pathology · doi:10.1080/00313020701329914 · Cited by 790
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
Beurel, E., & Jope, R. S. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.006 · Cited by 541
The Wnt signaling pathway and its role in tumor development
Lustig, B., & Behrens, J. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0431-0 · Cited by 524
Ding, Q., He, X., Hsu, J.-M., Xia, W., Chen, C.-T., Li, L.-Y., Lee, D.-F., Liu, J.-C., Zhong, Q., Wang, X., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00620-06 · Cited by 393
Young, M. R., Li, J.-J., Rincón, M., Flavell, R. A., Sathyanarayana, B. K., Hunziker, R., & Colburn, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9827 · Cited by 382
Glycogen synthase kinase-3: functions in oncogenesis and development
Plyte, S. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(92)90012-n · Cited by 378
c-fos is required for malignant progression of skin tumors
Saez, E., Rutberg, S. E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S. H., & Spiegelman, B. M. (1995) · Cell · doi:10.1016/0092-8674(95)90469-7 · Cited by 346
Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A., & Billadeau, D. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3642 · Cited by 327
Shakoori, A., Ougolkov, A., Yu, Z. W., Zhang, B., Modarressi, M. H., Billadeau, D. D., Mai, M., Takahashi, Y., & Minamoto, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.041 · Cited by 272
Wang, Y., Lam, J. B., Lam, K. S. L., Liu, J., Lam, M. C., Hoo, R. L. C., Wu, D., Cooper, G. J. S., & Xu, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1969 · Cited by 270
NF-κB: tumor promoter or suppressor?
Perkins, N. D. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.004 · Cited by 261
Lesort, M., Jope, R. S., & Johnson, G. V. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720576.x · Cited by 240
Huang, C., Ma, W.-Y., Young, M. R., Colburn, N., & Dong, Z. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.156 · Cited by 199
The Wnt connection to tumorigenesis
Behrens, J., & Lustig, B. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041815jb · Cited by 194
Ding, Q., He, X., Xia, W., Hsu, J.-M., Chen, C.-T., Li, L.-Y., Lee, D.-F., Yang, J.-Y., Xie, X., Liu, J.-C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1788 · Cited by 194
Ougolkov, A. V., Bone, N. D., Fernandez-Zapico, M. E., Kay, N. E., & Billadeau, D. D. (2007) · Blood · doi:10.1182/blood-2006-12-060947 · Cited by 187
Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
Cao, Q., Lu, X., & Feng, Y.-J. (2006) · Cell Research · doi:10.1038/sj.cr.7310078 · Cited by 186
Ougolkov, A. V., Fernández-Zapico, M. E., Bilim, V. N., Smyrk, T. C., Chari, S. T., & Billadeau, D. D. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0196 · Cited by 173
Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal Transitions
Doble, B. W., & Woodgett, J. R. (2007) · Cells Tissues Organs · doi:10.1159/000101306 · Cited by 170
Kinase-Inactive Glycogen Synthase Kinase 3β Promotes Wnt Signaling and Mammary Tumorigenesis
Farago, M., Dominguez, I. M., Landesman‐Bollag, E., Xu, X., Rosner, A., Cardiff, R. D., & Seldin, D. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1021 · Cited by 166
Inhibition of GSK‐3β activity attenuates proliferation of human colon cancer cells in rodents
Shakoori, A., Mai, W., Miyashita, K., Yasumoto, K., Takahashi, Y., Ooi, A., Kawakami, K., & Minamoto, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00545.x · Cited by 153
Role of glycogen synthase kinase-3 in cancer: Regulation by Wnts and other signaling pathways
Manoukian, A. S., & Woodgett, J. R. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)84007-6 · Cited by 143
Targeting Gsk-3: A Promising Approach For Cancer Therapy?
Ougolkov, A. V., & Billadeau, D. D. (2006) · Future Oncology · doi:10.2217/14796694.2.1.91 · Cited by 143
Hartigan, J. A., & Johnson, G. V. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21395 · Cited by 141
Mazor, M., Kawano, Y., Zhu, H., Waxman, J., & Kypta, R. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208068 · Cited by 136
The Role of Glycogen Synthase Kinase 3β in the Transformation of Epidermal Cells
Ma, C., Wang, J., Gao, Y., Gao, T., Chen, G., Bower, K. A., Odetallah, M., Ding, M., Ke, Z., & Luo, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4665 · Cited by 132
Self-citationTan, J. Y., Zhuang, L., Leong, H. S., Iyer, N. G., Liu, E. T., & Yu, Q. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1226 · Cited by 132
CK2 as a positive regulator of Wnt signalling and tumourigenesis
Seldin, D. C., Landesman‐Bollag, E., Farago, M., Currier, N. V., Lou, D. Y., & Dominguez, I. M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3078-0 · Cited by 131
Glycogen synthase kinase 3β is tyrosine phosphorylated by PYK2
Hartigan, J. A., Xiong, W.-C., & Johnson, G. V. W. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4986 · Cited by 117
Zhou, B. P., & Hung, M. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1744 · Cited by 115
Liao, X., Zhang, L., Thrasher, J. B., Du, J., & Li, B. (2003) · PubMed · Cited by 114
Zingarelli, B. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186079.88909.94 · Cited by 111
Role of Glycogen Synthase Kinase 3β in Rapamycin-Mediated Cell Cycle Regulation and Chemosensitivity
Dong, J., Peng, J., Zhang, H., Mondesire, W. H., Jian, W., Mills, G. B., Hung, M., & Meric‐Bernstam, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2501 · Cited by 111
Huang, C., Schmid, P. C., Ma, W.-Y., Schmid, H. O., & Dong, Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4187 · Cited by 109
Wnt-1 dependent activation of the survival factor NF-?B in PC12 cells
Bournat, J. C., Brown, A. M. C., & Soler, A. P. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000701)61:1<21::aid-jnr3>3.0.co;2-7 · Cited by 108
Baltzis, D., Pluquet, O., Papadakis, A. I., Kazemi, S., Qu, L.-K., & Koromilas, A. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704491200 · Cited by 107
Wnt Signaling as a Therapeutic Target for Cancer
Herbst, A., & Kolligs, F. T. (2006) · Humana Press eBooks · doi:10.1385/1-59745-208-4:63 · Cited by 91
Woodgett, J. R. (2003) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008033340153 · Cited by 90
Gotoh, J., Obata, M., Yoshie, M., Kasai, S., & Ogawa, K. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.435 · Cited by 85
Beurel, E., Kornprobst, M., Eggelpoël, M.-J. B.-V., Ruiz‐Ruiz, C., Cadoret, A., Capeau, J., & Desbois‐Mouthon, C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.001 · Cited by 82
Nuclear Factor-κB, an Unappreciated Tumor Suppressor
Chen, F., & Castranova, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1576 · Cited by 75
Erdal, E., Öztürk, N., Çağatay, T., Ekşioğlu, E., & Öztürk, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20972 · Cited by 71
Leis, H., Segrelles, C., Ruiz, S., Santos, M., & Paramio, J. M. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10087 · Cited by 64
Glycogen synthase kinase-3β is tyrosine-phosphorylated by MEK1 in human skin fibroblasts
Takahashi‐Yanaga, F., Shiraishi, F., Hirata, M., Miwa, Y., Morimoto, S., & Sasaguri, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.061 · Cited by 63
Soto‐Cerrato, V., Viñals, F., Lambert, J. R., Kelly, J. A., & Pérez‐Tomás, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0266 · Cited by 62
Cai, G., Wang, J., Xin, X., Ke, Z., & Luo, J. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.657 · Cited by 58
Self-citationGlycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?
Garcea, G., Manson, M. M., Neal, C. P., Pattenden, C. J., Sutton, C. D., Dennison, A. R., & Berry, D. P. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780618266 · Cited by 58
Expression of Cyclooxygenase-2 Is Regulated by Glycogen Synthase Kinase-3β in Gastric Cancer Cells
Thiel, A., Heinonen, M., Rintahaka, J., Hallikainen, T., Hemmes, A., Dixon, D. A., Haglund, C. H., & Ristimaki, A. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m512722200 · Cited by 55
Li, Z., Tan, F., & Thiele, C. J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0133 · Cited by 50
Kim, S. D., Yang, S., Kim, H., Shin, C. Y., & Ko, K. H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.018 · Cited by 49
Sui, Z., Sniderhan, L. F., Fan, S., Kaźmierczak, K., Reisinger, E., Kovács, A., Potash, M. J., Dewhurst, S., Gelbard, H. A., & Maggirwar, S. B. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04813.x · Cited by 48
Glycogen Synthase Kinase 3 beta.
Dajani, R., Pearl, L. H., & Roe, S. M. (2001) · Worldwide Protein Data Bank · doi:10.2210/pdb1h8f/pdb · Cited by 30
GSK-3β reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis
Beurel, E., Kornprobst, M., Eggelpoël, M.-J. B.-V., Cadoret, A., Capeau, J., & Desbois‐Mouthon, C. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.1.215 · Cited by 29
Billadeau, D. D. (2007) · Pancreatology · doi:10.1159/000108955 · Cited by 27
Cited by
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
GSK-3 as potential target for therapeutic intervention in cancer
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2037 · Cited by 508
Activators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
Triterpenoids as new promising anticancer drugs
Petronelli, A., Pannitteri, G., & Testa, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330fd90 · Cited by 381
Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
Wang, W., Nag, S., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106124315 · Cited by 282
Metadata
- Authors
- Luo, J.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 273
- Issue
- 2
- Pages
- 194-200
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2114594254
- Cited by
- 429
- References
- 59
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.